INS and Hyperglycemia: For cases of transient diabetes, insulin therapy using CSII and CGM systems seems to remain a safe and successful treatment until the results of genetic testing are obtained, hyperglycemia is resolved, or until a decision is made to implement oral sulfonylureas.